New Budget Bill Short Shrifts Science

The omnibus spending bill unveiled by US Congress this week would restore some research budgets cut by sequestration, but critics say it's not enough.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, KMCCOYThe US Congress rolled out an omnibus $1.1 trillion spending bill on Monday (January 13) that would keep the government in operation through October. The bipartisan bill, which was authored by House Appropriations Committee Chairman Harold Rogers (R-KY) and Senate counterpart Barbara Mikulski (D-MD), slates $29.934 billion in funding for the National Institutes of Health (NIH), a $1 billion increase from the agency’s sequester-wracked 2013 budget.

But this boost isn’t large enough, according to many in the research community. “The FY14 omnibus spending bill falls short of restoring funding for lifesaving National Institutes of Health (NIH) biomedical research,” said Carrie Wolinetz, president of the biomedical science advocacy group United for Medical Research, in a statement. “The proposed package won’t adequately reverse the damage done by last year’s budget sequester and ensure the nation’s biomedical research enterprise makes continued progress in lifesaving research and development.”

The NIH budget increase contained in the spending bill is, in fact, $714 million less than 2013’s “enacted level” of $30.648 billion, according to House Democrats. And the NIH itself reports that if the bill were to pass, the agency would be getting $950 million less than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo